Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.924 USD | -2.74% | +33.23% | -35.45% |
27/03 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
26/03 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.45% | 47.3M | |
+73.38% | 12.38B | |
-17.17% | 7.99B | |
+16.97% | 7.21B | |
+3.57% | 5.79B | |
+11.77% | 5.35B | |
+29.65% | 4.63B | |
-17.74% | 4.17B | |
-35.69% | 2.44B | |
+3.09% | 2.03B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Sector Update: Health Care